TissueScan, Melanoma cDNA Array II
SKU
MERT102
40 samples covering 3-normal, 1-stage IIIA, 3-IIIB, 2-IIIC, 9-III 22-IV. Available in 2, 5, 10 identical plates.
$1,060.00
In Stock*
Specifications
Reviews
Documents
| Product Manuals |
| FAQs |
| SDS |
Citations
An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition
Young, Rowling, Bugatti et al
J. Exp. Med. (2017)
Young, Rowling, Bugatti et al
J. Exp. Med. (2017)
Renalase expression by melanoma and tumor associated-macrophages promotes tumor growth through a STAT3-mediated mechanism
Hollander, Guo, Velazquez et al
Cancer Res. (2016)
Hollander, Guo, Velazquez et al
Cancer Res. (2016)
AI Summary: OriGene contributed to this study by providing Human melanoma cDNA arrays (TissueScan cDNA arrays), which were used to analyze RNLS expression in melanoma tissue specimens.
Snippet: Tissue specimens Human melanoma cDNA arrays I and II were obtained from OriGene Technologies (Rockville, MD, USA). The relevant pathology reports are available online: http://www.origene.com/assets/documents/TissueScan. ... Cite SaveSaving
Effect of SMURF2 targeting on susceptibility to MEK inhibitors in melanoma
Smith, Ferguson, Arozarena et al
J. Natl. Cancer Inst. (2013) 105 (1), 33-46 DOI: 10.1093/jnci/djs471
Smith, Ferguson, Arozarena et al
J. Natl. Cancer Inst. (2013) 105 (1), 33-46 DOI: 10.1093/jnci/djs471
Cited by 106
AI Summary: OriGene’s TissueScan cDNA arrays (MERT101 and MERT102) were used in this study to analyze the expression of SMURF2 and PAX3 in melanoma samples, contributing to the investigation of molecular mechanisms underlying melanoma susceptibility to MEK inhibitors.
Snippet: effect or after continuous long-term exposure to the drug (6–8). However, dose-limiting toxicity or a short half-life of the ... Two melanoma TissueScan cDNA arrays, MERT101 and MERT102 (Origene, Rockville, MD), were analyzed for the expression of SMURF2 and PAX3.
Membrane-type-3 matrix metalloproteinase (MT3-MMP) functions as a matrix composition-dependent effector of melanoma cell invasion
Tatti, Arjama, Ranki et al
PLoS ONE (2011) 6 (12), e28325 DOI: 10.1371/journal.pone.0028325
Tatti, Arjama, Ranki et al
PLoS ONE (2011) 6 (12), e28325 DOI: 10.1371/journal.pone.0028325
Cited by 49
AI Summary: In this study, OriGene's MT3-MMP (Cat# SC118188) and MT1-MMP (Cat# SC117519) siRNAs were used to selectively silence gene expression in melanoma cells, enabling the authors to dissect the distinct roles of these metalloproteinases in regulating matrix-dependent tumor invasion.
Snippet: siRNAs in WM852 cells (over 80% silencing efficiencies by qPCR;Fig. 3A). The down-regulation of MT1-MMP or MT3-MMP protein was confirmed by immunoblotting (Fig. 3B and C). MT3-MMP, which was detected as the major
Showing 1-4 of 4 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.
Related Products
- Price:
- Actual Price:
Welcome to OriGene AI!
I'm your AI-powered guide to everything OriGene.
Ask me anything:
- Product specs
- Ordering help
- Technical questions
- How to find exactly what your experiment needs
Prefer a live agent? Connect with us by clicking the green chat icon, as seen in the image below or email our team at custsupport@origene.com.
